NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
This Quarter Return
+7.55%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$999M
AUM Growth
+$999M
(+27%)
Cap. Flow
+$107M
Cap. Flow
% of AUM
10.73%
Top 10 Holdings %
Top 10 Hldgs %
44.45%
Holding
134
New
12
Increased
32
Reduced
54
Closed
15
Top Buys
| 1 |
Soleno Therapeutics
SLNO
|
$99.2M |
| 2 |
Evolus
EOLS
|
$26.2M |
| 3 |
RDNW
RideNow Group, Inc. Class B Common Stock
RDNW
|
$22.9M |
| 4 |
iShares Russell 2000 ETF
IWM
|
$15.3M |
| 5 |
Establishment Labs
ESTA
|
$15.1M |
Top Sells
| 1 |
Tourmaline Bio
TRML
|
$66.6M |
| 2 |
Fortress Biotech
FBIO
|
$17M |
| 3 |
Pathward Financial
CASH
|
$9.24M |
| 4 |
Instil Bio
TIL
|
$6.65M |
| 5 |
Cytokinetics
CYTK
|
$5.78M |
Sector Composition
| 1 | Healthcare | 59.27% |
| 2 | Consumer Discretionary | 14.15% |
| 3 | Financials | 7.37% |
| 4 | Communication Services | 5.83% |
| 5 | Technology | 4.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Soleno Therapeutics
SLNO
$3.6B
| $115M | 6.87% | 2,856,351 +2,463,947 | +628% | +$99.2M |
|
|
2
Establishment Labs
ESTA
$1.2B
| $64M | 3.82% | 2,470,154 +582,537 | +31% | +$15.1M |
|
|
3
Pathward Financial
CASH
$1.82B
| $56.1M | 3.35% | 1,059,866 -174,660 | -14% | -$9.24M |
|
4
IMAX
IMAX
$1.54B
| $36.2M | 2.16% | 2,408,753 -198,131 | -8% | -$2.98M |
|
|
RDNW
5
RideNow Group, Inc. Class B Common Stock
RDNW
$147M
| $36M | 2.15% | 4,416,506 +2,811,114 | +175% | +$22.9M |
|
6
Bioventus
BVS
$495M
| $31.5M | 1.88% | 5,977,471 -41,061 | -0.7% | -$216K |
|
|
7
Evolus
EOLS
$494M
| $30.7M | 1.83% | 2,910,849 +2,489,629 | +591% | +$26.2M |
|
8
Hilton Grand Vacations
HGV
$4.24B
| $27M | 1.61% | 671,171 +166,929 | +33% | +$6.71M |
|
9
Red Violet
RDVT
$702M
| $24.1M | 1.44% | 1,205,678 -56,218 | -4% | -$1.12M |
|
10
America's Car Mart
CRMT
$371M
| $23.6M | 1.41% | 312,128 +81,175 | +35% | +$6.15M |
|
11
Lyra Therapeutics
LYRA
$11.5M
| $21.2M | 1.27% | 4,050,218 | – | – |
|
12
uniQure
QURE
$896M
| $20M | 1.2% | 2,958,027 -65,772 | -2% | -$445K |
|
13
Peloton Interactive
PTON
$3.1B
| $19.9M | 1.19% | 3,262,939 -291,667 | -8% | -$1.78M |
|
|
14
iShares Russell 2000 ETF
IWM
$67B
| $19.7M | 1.18% | 97,969 +76,091 | +348% | +$15.3M |
|
15
Luxfer Holdings
LXFR
$359M
| $16.2M | 0.97% | 1,809,645 -311,517 | -15% | -$2.78M |
|
16
Zevra Therapeutics
ZVRA
$509M
| $16.1M | 0.96% | 2,453,405 +145,189 | +6% | +$951K |
|
17
Viemed Healthcare
VMD
$286M
| $15.3M | 0.92% | 1,952,368 -79,802 | -4% | -$626K |
|
18
Immatics
IMTX
$619M
| $14.9M | 0.89% | 1,413,956 -506,680 | -26% | -$5.34M |
|
19
Amneal Pharmaceuticals
AMRX
$3B
| $14.2M | 0.85% | 2,334,397 +121,640 | +5% | +$738K |
|
20
Codexis
CDXS
$246M
| $14M | 0.84% | 4,592,903 -476,540 | -9% | -$1.45M |
|
21
Keros Therapeutics
KROS
$618M
| $12.3M | 0.74% | 310,141 -18,640 | -6% | -$741K |
|
22
Neuropace
NPCE
$303M
| $12.1M | 0.72% | 1,173,677 -46,238 | -4% | -$477K |
|
23
Noodles & Co
NDLS
$33.1M
| $11.8M | 0.71% | 3,744,571 +248,744 | +7% | +$784K |
|
24
Aura Biosciences
AURA
$389M
| $11.7M | 0.7% | 1,321,860 +577,968 | +78% | +$5.12M |
|
25
Golden Entertainment
GDEN
$651M
| $11.6M | 0.7% | 291,449 -40,607 | -12% | -$1.62M |
|